Opinion: Large pharmaceutical companies need to support the growth of startups
The productivity crisis that has challenged the pharmaceutical industry for years shows no sign of abating. Contrary to the popular opinion that the industry simply doesn’t spend enough on research, budgets for research and development have actually increased over the last 10 years. Yet R&D productivity continues to stagnate.
Having spent more than 30 years working with pharmaceutical companies on their research and development strategies, and before that as a researcher in such companies, I’ve seen firsthand the considerable resources poured into R&D and the bottlenecks that slow innovation. Pharmaceutical companies are some of the most conservative organizations on the significance of “the cloud.” In 2017, while adoption of cloud infrastructure is gradually increasing, it is yet to be fully embraced.
You’re reading a preview, subscribe to read more.
Start your free 30 days